Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 08:47:55 28/02/2017 +04 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.67M 2.46M 2.31M 4.31M 295M 4.4M 29.39M 11.38M 142M 11.56M 11.31M 494M P/E Ratio 2017
-6.41x
P/E Ratio 2018 -3.16x
Enterprise Value 3.63M 3.15M 2.9M 2.72M 5.08M 347M 5.19M 34.62M 13.4M 167M 13.62M 13.33M 582M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
-0.35%+0.97%-15.96%-12.73% 42.96B
+2.86%+2.92%+273.61%+506.84% 31.73B
-0.56%-2.27%+12.67%-15.39% 30.22B
+1.59%-1.95%-4.23%+24.22% 28.94B
+4.09%-1.98%+11.99%+17.37% 23.87B
-0.93%+3.44%+54.56%+115.51% 13.57B
-0.40%-1.29%+6.06%+7.59% 12.96B
+1.97%+5.01% - - 13.39B
-1.59%-1.97%+104.98%+75.39% 12.2B
Average +10.64%+9.36%+55.46%+89.85% 20.98B
Weighted average by Cap. +0.86%-1.08%+54.17%+95.55%

Financials

2017 2018
Net sales 16.01K 13.89K 12.81K 12K 22.42K 1.53M 22.89K 153K 59.15K 739K 60.1K 58.81K 2.57M 124 107.61 99.19 92.94 173.65 11.87K 177.27 1.18K 458.11 5.72K 465.5 455.46 19.9K
Net income -481K -417K -385K -360K -674K -46.05M -688K -4.59M -1.78M -22.2M -1.81M -1.77M -77.18M -976K -847K -780K -731K -1.37M -93.41M -1.39M -9.31M -3.6M -45.03M -3.66M -3.58M -157M
Net Debt 497K 431K 397K 372K 696K 47.56M 710K 4.74M 1.84M 22.93M 1.86M 1.82M 79.72M 548K 476K 439K 411K 768K 52.5M 784K 5.23M 2.03M 25.31M 2.06M 2.01M 88M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!